XNAS
WORX
Market cap179kUSD
Jul 09, Last price
0.66USD
1D
96.18%
1Q
-57.05%
Jan 2017
-100.00%
IPO
-100.00%
Name
Scworx Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various medical establishments across the United States. The company delivers a broad spectrum of data-focused services, encompassing the repair, standardization, and interoperability of healthcare information for providers, alongside delivering sophisticated big data analytics for the sector. Its diverse offerings include virtualized item master file repair, expansion, and automation; management of electronic medical records (EMR) and charge description masters (CDM); optimization of contract management; automation of request for proposal (RFP) and rebate processes; integration of acquired management systems; big data analytics modeling; data integration and warehousing; and its proprietary ScanWorx solution. Beyond its core healthcare IT endeavors, SCWorx has diversified into other areas. It operates CageTix, an online event ticketing platform specifically targeting regional mixed martial arts events. Additionally, the company is involved in the provision of personal protective equipment (PPE) and rapid COVID-19 test kits. SCWorx distributes its specialized solutions and services to hospitals and health systems through a multi-channel approach, leveraging both its internal sales team and strategic distribution and reseller partnerships.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||